NRAD1 Gene

Name non-coding RNA in the aldehyde dehydrogenase 1A pathway
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nNRAD1, also known as LINC00284, was initially identified in triple‐negative breast cancer (TNBC) and cancer stem cells (CSCs) as a long non‐coding RNA highly enriched in these aggressive cells. Its expression is regulated by ALDH1A3 and retinoic acid, and NRAD1 predominantly localizes to the nucleus where it interacts with chromatin and modulates gene expression—particularly genes involved in differentiation and catabolic processes. Targeting NRAD1 using antisense oligonucleotides reduced cell survival, tumor growth, and the CSC phenotype in TNBC models, establishing NRAD1 as a critical downstream effector in this pathway."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn serous ovarian carcinoma (SOC), NRAD1/LINC00284 was found to be significantly overexpressed and integrated into a competitive endogenous RNA (ceRNA) network with the transcription factor SOX9, among other molecules. High levels of LINC00284 in SOC patients correlated with poor prognosis, suggesting that this lncRNA not only contributes to carcinogenesis but may also serve as a potential prognostic biomarker and therapeutic target in ovarian cancer."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn the context of intervertebral disc degeneration (IDD), LINC00284 (NRAD1) appears to play a pathogenic role by inhibiting nucleus pulposus (NP) cell proliferation and extracellular matrix (ECM) synthesis. Mechanistically, LINC00284 functions by sponging miR‑205‑3p, thereby activating Wnt/β‑catenin signaling which facilitates ECM degradation. Knockdown of LINC00284 in both in vitro and in vivo models was shown to mitigate these detrimental changes, highlighting its involvement in IDD progression."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn a separate study aimed at predicting adverse pregnancy outcomes in women with systemic lupus erythematosus (SLE), NRAD1 was not specifically implicated, and no functional role of this lncRNA was described in that context."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": ""}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Dejan Vidovic, Thomas T Huynh, Prathyusha Konda, et al. "}, {"type": "b", "children": [{"type": "t", "text": "ALDH1A3-regulated long non-coding RNA NRAD1 is a potential novel target for triple-negative breast tumors and cancer stem cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Differ (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41418-019-0362-1"}], "href": "https://doi.org/10.1038/s41418-019-0362-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31197235"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31197235"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Shasha Wang, Lu Zhang, Lin Tao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Construction and Investigation of an LINC00284-Associated Regulatory Network in Serous Ovarian Carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Dis Markers (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2020/9696285"}], "href": "https://doi.org/10.1155/2020/9696285"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32076467"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32076467"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Min Zhu, Xiaoling Yan, Yin Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "lncRNA LINC00284 promotes nucleus pulposus cell proliferation and ECM synthesis via regulation of the miR‑205‑3p/Wnt/β‑catenin axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2022.12695"}], "href": "https://doi.org/10.3892/mmr.2022.12695"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35322864"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35322864"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Yu Deng, Yiran Zhou, Jiangcheng Shi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Potential genetic biomarkers predict adverse pregnancy outcome during early and mid-pregnancy in women with systemic lupus erythematosus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Front Endocrinol (Lausanne) (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3389/fendo.2022.957010"}], "href": "https://doi.org/10.3389/fendo.2022.957010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36465614"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36465614"}]}]}]}
NCBI Gene ID 121838
API
Download Associations
Predicted Functions View NRAD1's ARCHS4 Predicted Functions.
Co-expressed Genes View NRAD1's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View NRAD1's ARCHS4 Predicted Functions.

Functional Associations

NRAD1 has 0 functional associations with biological entities spanning 0 categories () extracted from 0 datasets.

Click the + buttons to view associations for NRAD1 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary